Main > DERMATOLOGY > Psoriasis>Plaque Psoriasis (**) > Treatment > Co: DE. B. AdalimuMAb BioSimilar *

---

Co: DE. B. AdalimuMAb BioSimilar *'s subsections
(*) EU Approval Date: 2017. 11.13
(*) USA Approval Date: 2017. 08.29
Company
TradeMark
TradeMark Web-Site

Co: DE. B. AdalimuMAb BioSimilar *'s products
This section has no products